The SJD-Hospital Bellvitge Hereditary Retinal Dystrophy Unit has applied Novartis' Luxturna therapy to Noa, who only retained 3% of her vision.
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
Research led by IIBB-CSIC and CIBEREHD scientists identifies S-adenosy...